Technology appraisal TA217 Alzheimer's disease – donepezil, galantamine, rivastigmine and memantine
This guidance replaces NICE technology appraisal guidance 111 issued in November 2006 (amended September 2007, August 2009). Read more »
Dementia Partnerships